P.A.W. Capital Corp Reata Pharmaceuticals Inc Transaction History

P.A.W. Capital Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$74.57 - $217.92 $1.04 Million - $3.05 Million	-14,000 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$71.26 - $95.75 $71,260 - $95,750	-1,000 Reduced 6.67%	14,000 $1.12 Million
Q2 2019 Jul 31, 2019	SELL	$77.72 - $94.35 $777,200 - $943,500	-10,000 Reduced 40.0%	15,000 $1.42 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $76.44 $53,636 - $84,084	1,100 Added 4.6%	25,000 $1.4 Million
Q3 2018 Oct 24, 2018	SELL	$35.64 - $92.06 $573,804 - $1.48 Million	-16,100 Reduced 40.25%	23,900 $1.95 Million
Q2 2018 Jul 25, 2018	SELL	$19.94 - $40.96 $398,800 - $819,200	-20,000 Reduced 33.33%	40,000 $1.4 Million
Q1 2018 Apr 26, 2018	BUY	$20.0 - $30.19 $400,000 - $603,800	20,000 Added 50.0%	60,000 $1.23 Million
Q4 2017 Jan 31, 2018	BUY	$22.39 - $33.27 $223,900 - $332,700	10,000 Added 33.33%	40,000 $1.13 Million
Q3 2017 Oct 23, 2017	BUY	$26.29 - $31.88 $788,700 - $956,400	30,000	30,000 $933,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.